Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment

BACKGROUND: Standard-duration (7–10 days) thromboprophylaxis with low molecular weight heparin, low dose unfractionated heparin, or fondaparinux in hospitalized medically ill patients is associated with ~50% reduction in venous thromboembolism (VTE) risk. However, these patients remain at high risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Yami, Majed S, Kurdi, Sawsan, Abraham, Ivo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826205/
https://www.ncbi.nlm.nih.gov/pubmed/29503590
http://dx.doi.org/10.2147/JBM.S149202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826205/
https://www.ncbi.nlm.nih.gov/pubmed/29503590
http://dx.doi.org/10.2147/JBM.S149202

Ejemplares similares